Vadivarhe Speciality Chemicals reports standalone net loss of Rs 1.87 crore in the June 2021 quarter

Vadivarhe Speciality Chemicals reports standalone net loss of Rs 0.93 crore in the December 2020 quarter

Vadivarhe Speciality Chemicals reports standalone net loss of Rs 0.71 crore in the June 2020 quarter

Sunil Pophale, CMD, Vadivarhe Speciality Chemicals states that he expects margin to remain between 30-35%.

Expect Margin To Remain Between 30-35%: Vadivarhe Speciality

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Vadivarhe Speciality Chemicals is engaged in the business of manufacturing of specialty chemicals, active pharmaceutical ingredients, intermediates, personal care ingredients and marketing of neutraceutical (food & health supplementary) products